|
⚲
|
| Keyboard |
| Nessi Claudio
✚
|
|
|---|---|
| CIK # | 0001722050 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001722050] | |
| 4 | [0001722050] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 1,415,865 | ||
|
Lexeo Therapeutics Inc LXEO
Series A convertible preferred stock · derivative
|
2023-11-07 | Conversion | 14,999,999 | ||
|
Lexeo Therapeutics Inc LXEO
Series B convertible preferred stock · derivative
|
2023-11-07 | Conversion | 2,615,533 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Buy | 454,545 | $11.00 | 4,999,995 |
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 287,213 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Theseus Pharmaceuticals Inc THRX
Series B Preferred Stock · derivative
|
2021-10-12 | Conversion | 693,152 | ||
|
Theseus Pharmaceuticals Inc THRX
Common Stock
|
2021-10-12 | Conversion | 523,979 | ||
|
Panacea Acquisition Corp NUVB
Class A Common Stock
|
2021-02-10 | Conversion | 8,130,097 | ||
|
Panacea Acquisition Corp NUVB
Series A Preferred Stock · derivative
|
2021-02-10 | Conversion | 8,130,097 | $0.00 | |
|
Panacea Acquisition Corp NUVB
Class A Common Stock
|
2021-02-10 | Grant | 500,000 | $10.00 | 5,000,000 |
|
Kronos Bio Inc KRON
Series Seed Preferred Stock · derivative
|
2020-10-14 | Conversion | 1,522,484 | ||
|
Kronos Bio Inc KRON
Common Stock
|
2020-10-14 | Conversion | 1,376,313 | ||
|
Kronos Bio Inc KRON
Common Stock
|
2020-10-14 | Conversion | 366,299 | $16.15 | 5,915,729 |
|
Kronos Bio Inc KRON
Common Stock
|
2020-10-14 | Buy | 450,000 | $19.00 | 8,550,000 |
|
Kronos Bio Inc KRON
Common Stock
|
2020-10-14 | Conversion | 1,606,220 | ||
|
Kronos Bio Inc KRON
Convertible Promissory Note · derivative
|
2020-10-14 | Conversion | $0.00 | ||
|
Kronos Bio Inc KRON
Series A Preferred Stock · derivative
|
2020-10-14 | Conversion | 1,304,563 | ||
|
Morphic Holding Inc MORF
Series B Preferred Stock · derivative
|
2019-07-01 | Conversion | 1,978,779 | $0.00 | |
|
Morphic Holding Inc MORF
Common Stock
|
2019-07-01 | Conversion | 1,978,779 | ||
| showing 20 of 48 most recent transactions | |||||